Health

For your perfect skin

BOOSTING THE quality of your diet checks a lot of boxes for your health. Weight, energy, and proper nutrition come to mind first. The health of your skin should be added to that list as nutritional skincare illuminates the natural radiance of your...

BOOSTING THE quality of your diet checks a lot of boxes for your health. Weight, energy, and proper nutrition come to mind first. The health of your skin should be added to that list as nutritional skincare illuminates the natural radiance of your...

1 year 10 months ago

Healio News

COVID-19 lockdowns may have caused myopic shift in children

Mandatory online schooling and confinement during the COVID-19 pandemic may have exacerbated myopia in school-aged children in Puerto Rico, according to a review published in Optometry and Vision Science.“Online learning increased students’ time on electronics indoors and reduced their time outside during the COVID-19 pandemic quarantine,” study author Neisha M.

Rodriguez, OD, PhD, MPH, associate professor at Inter American University of Puerto Rico School of Optometry, and colleagues wrote. “The previously mentioned factors are believed to increase a child’s

1 year 10 months ago

Health – Demerara Waves Online News- Guyana

Mahdia dorm fire victim discharged from New York’s Staten Island hospital 3 months after fatal blaze

STATEN ISLAND, New York City (WABC) — It’s been three long months of surgeries, skin grafts, physical rehabilitation, and grief counseling. But Monday, three months to the day of a fatal fire that claimed the lives of 20 students in a girl’s dormitory in Guyana, the most critically burned patient will be discharged. Mariza Williams was ...

STATEN ISLAND, New York City (WABC) — It’s been three long months of surgeries, skin grafts, physical rehabilitation, and grief counseling. But Monday, three months to the day of a fatal fire that claimed the lives of 20 students in a girl’s dormitory in Guyana, the most critically burned patient will be discharged. Mariza Williams was ...

1 year 10 months ago

Health, News

Health – Dominican Today

Public Health activated the Contingency Plan for the threat of Tropical Storm Franklin

Santo Domingo.- The Ministry of Public Health (MSP) has taken proactive steps by activating its National Contingency Plan to mitigate the potential impact of tropical storm Franklin, anticipated for Tuesday, August 22, as forecasted by the National Meteorological Office (ONAMET).

Santo Domingo.- The Ministry of Public Health (MSP) has taken proactive steps by activating its National Contingency Plan to mitigate the potential impact of tropical storm Franklin, anticipated for Tuesday, August 22, as forecasted by the National Meteorological Office (ONAMET).

Leading a coordination meeting with vice ministers and directors of the institution, Minister of Health, Dr. Daniel Rivera, instructed the Rapid Response Teams to initiate actions in line with the “Assessment of Damages and Analysis of Health Needs in Emergency Situations (EDAN-Salud).” This collaboration takes place in coordination with the Emergency Operations Center (COE).

Dr. Rivera emphasized the paramount importance of safeguarding the public’s health. He urged all personnel to be ready to respond to any emerging emergency situations arising from the impending weather phenomenon, as indicated by meteorological predictions. Preventing disease transmission is crucial, as episodes such as diarrhea, dengue fever, malaria, and other ailments tend to escalate during hurricane season and heavy rainfall periods. The implementation of effective health measures can mitigate the potential consequences.

Dr. Gina Estrella, Director of Risk Management and Disaster Care, noted that the Ministry of Health has been in a continuous session due to the looming threat of the storm. This state of readiness extends to both headquarters and Provincial Directorates and Health Areas. Dr. Estrella called upon local authorities to take appropriate actions to ensure the well-being and safety of residents in their jurisdictions. Special attention is given to provinces under alert, particularly Pedernales and Dajabón, where the storm’s impact is expected to be most pronounced.

Assured provision of medicines, supplies, and necessary resources is a priority for the Ministry to effectively assist those in need during the crisis.

Key actions include:

– Activation of the COE-Health in a continuous session.
– Ongoing monitoring from the Situation Room of the Directorate of Risk Management and Disaster Assistance.
– Activation of Provincial Health Committees, integration of Provincial and Municipal COEs, and response plan activation for hospitals in respective jurisdictions.
– Evaluation of temporary shelters identified by Civil Defense for authorization.
– Inventory of available resources for response needs.
– Activation of local rapid response teams.

The Ministry of Health underscores the importance of preventive measures during the rainy season. In particular, increased occurrences of acute respiratory diseases, epidemics, and the potential spread of diseases like dengue, leptospirosis, acute diarrheal disease, Covid-19, and others. Precautionary steps include practicing permanent hand washing, ensuring the safety of drinking water, maintaining hygienic practices for food and utensils, using tissues when sneezing, protecting vulnerable groups, and being equipped with necessary medications.

The Emergency Operations Center has placed the entire country under alert. The southern coast is on red alert, the central region and extreme east are on yellow alert, and the north and northeast coasts are on green alert. The forecast anticipates heavy rainfall across the nation due to the direct impact of the storm.

1 year 10 months ago

Health

Healio News

Epcoritamab plus R-CHOP achieve high response rates in untreated high-risk DLBCL

CHICAGO — Epcoritamab plus R-CHOP induced high complete metabolic response rates in previously untreated high-risk diffuse large B-cell lymphoma and double-hit or triple-hit lymphoma, according to research presented at ASCO Annual Meeting.The study, presented by Lorenzo Falchi, MD, evaluated 46 patients with previously untreated high-risk DLBCL , 11 of whom had double-hit or triple-hit lymphoma

. Patients received 48 mg epcoritamab (DuoBody-CD3xCD20; Genmab, AbbVie) plus R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone).Of these patients, 100% had a response

1 year 10 months ago

Health – Dominican Today

Government initiates purchase of Maharishi’s land; a hospital would be built

Santo Domingo.- Elías Matos, a deputy representing Constituency One of the National District for the Modern Revolutionary Party (PRM), highlighted on Monday that the Dominican Government has initiated the process of acquiring the land previously occupied by the Maharishi school.

Santo Domingo.- Elías Matos, a deputy representing Constituency One of the National District for the Modern Revolutionary Party (PRM), highlighted on Monday that the Dominican Government has initiated the process of acquiring the land previously occupied by the Maharishi school. This land is being considered for the construction of a much-needed major hospital, especially in the southern region of the capital.

Matos specified that he has been advocating for the establishment of a large hospital to serve the sectors in the southern part of Constituency One and the entire National District since September 2020.

“We have received information that the Dominican Government has begun the necessary steps to acquire the land of the old Maharishi College,” stated the legislator. He also mentioned that the premises encompass an area of over 50,000 square meters, which could be repurposed for this purpose.

The legislator, who aligns with the ruling party, emphasized his commitment to the concept of creating a comprehensive hospital in Constituency One. He envisioned a hospital with specialized units such as geriatrics, pediatrics, traumatology, and a burn unit, among other healthcare specialties.

Matos expressed confidence that the Dominican Government will heed the voices of the citizens who are eager for a high-quality and accessible healthcare service. He noted that the hospital’s strategic location would help alleviate congestion in other healthcare centers and expedite assistance from the National Emergency and Security System 9-1-1.

Elías Matos acknowledged President Luis Abinader’s responsiveness to the needs of the people and expressed optimism that an official announcement regarding the construction of the major hospital in the southern part of the National District will be forthcoming in the upcoming days.

It is worth noting that on September 18, 2020, Deputy Elías Matos, representing Constituency One of the National District for the Modern Revolutionary Party, submitted a draft resolution through the General Legislative Secretariat of the Chamber of Deputies. In the resolution, he urged President Luis Abinader to consider the construction of a general hospital in the Miramar sector, located at kilometer 8 of Independencia Avenue.

In his address, the deputy highlighted that the population in the sectors of the National District exceeds 315,000 people, with a population density approaching 8,000 inhabitants per square kilometer. He emphasized the need for a general hospital in this area to alleviate pressure on other healthcare centers in the city, particularly within the coastal strip between the 30 de Mayo highway and the Sánchez highway, which accommodates around 200,000 residents.

1 year 10 months ago

Health

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Blue-light filtering spectacles may make no difference to eye strain, eye health or sleep quality

Spectacles that are marketed to filter out blue light probably make no difference to eye strain caused by computer use or to sleep quality, according to a review of 17 randomised controlled trials of the best available evidence so far.

Nor did the review find any evidence that blue-light filtering lenses protect against damage to the retina, the light-sensitive tissue at the back of the eye, as included studies did not evaluate this outcome. Blue-light filtering lenses, also known as blue-light blocking spectacles, have been increasingly prescribed or recommended, often by optometrists, since the early 2000s.

The new review, published in the Cochrane Database of Systematic Reviews, was led by researchers at the University of Melbourne in collaboration with colleagues at City, University of London and Monash University.

The team set out to assess the effects of blue-light filtering lenses compared with non-blue-light filtering lenses for improving visual performance, providing protection to the retina and improving sleep quality. They analysed data from all the randomised controlled trials they could find on the topic and found 17 trials from six countries. The numbers of participants in individual studies ranged from five to 156, and the period of time over which the lenses were assessed ranged from less than one day to five weeks.

The senior author of the review is Associate Professor Laura Downie, Dame Kate Campbell Fellow and Head of the Downie Laboratory: Anterior Eye, Clinical Trials and Research Translation Unit, at the University of Melbourne, Victoria, Australia.

She said: “We found there may be no short-term advantages with using blue-light filtering spectacle lenses to reduce visual fatigue associated with computer use, compared to non-blue-light filtering lenses. It is also currently unclear whether these lenses affect vision quality or sleep-related outcomes, and no conclusions could be drawn about any potential effects on retinal health in the longer term. People should be aware of these findings when deciding whether to purchase these spectacles.”

However, the quality and duration of the studies also needs to be considered, she said.

“We performed the systematic review to Cochrane methodological standards to ensure the findings are robust. However, our certainty in the reported findings should be interpreted in the context of the quality of the available evidence. The short follow-up period also affected our ability to consider potential longer-term outcomes.”

The first author of the review, Dr Sumeer Singh, a postdoctoral research fellow in the Downie Laboratory, said: “High-quality, large clinical research studies with longer follow-up in more diverse populations are still required to ascertain more clearly the potential effects of blue-light filtering spectacle lenses on visual performance, sleep and eye health. They should examine whether efficacy and safety outcomes vary between different groups of people and using different types of lenses.”

The review did not find any consistent reports of adverse side effects from using blue-light filtering lenses. Any effects tended to be mild, infrequent and temporary. They included discomfort wearing the spectacles, headaches and lower mood. These were likely to be related to the wearing of spectacles generally, as similar effects were reported with non-blue-light filtering lenses.

Prof. Downie said: “Over the past few years, there has been substantial debate about whether blue-light filtering spectacle lenses have merit in ophthalmic practice. Research has shown that these lenses are frequently prescribed to patients in many parts of the world, and a range of marketing claims exist about their potential benefits, including that they may reduce eye strain associated with digital device use, improve sleep quality and protect the retina from light-induced damage. The outcomes of our review, based on the current, best available evidence, show that the evidence is inconclusive and uncertain for these claims. Our findings do not support the prescription of blue-light filtering lenses to the general population. These results are relevant to a broad range of stakeholders, including eye care professionals, patients, researchers and the broader community.”

The potential mechanisms by which blue-light filtering lenses might be able to help with eye strain, sleep and protecting the retina are unclear. One basis for claims about the benefits of these lenses is that modern digital devices such as computers and smart phones emit more blue light than traditional lighting sources, and are being used for longer, and closer to bedtime.

Dr Singh said: “The amount of blue light our eyes receive from artificial sources, such as computer screens, is about a thousandth of what we get from natural daylight. It’s also worth bearing in mind that blue-light filtering lenses typically filter out about 10-25% of blue light, depending on the specific product. Filtering out higher levels of blue light would require the lenses to have an obvious amber tint, which would have a substantial effect on colour perception.”

Reference:

Downie LE, Keller PR, Busija L, Lawrenson JG, Hull CC. Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database Syst Rev. 2019 Jan 16;2019(1):CD013244. doi: 10.1002/14651858.CD013244. 

1 year 10 months ago

Ophthalmology,Ophthalmology News,Latest Medical News

Health – Dominican Today

ADTS announces investment of more than 12 billion pesos in medical tourism

The directors of the Dominican Association of Health Tourism (ADTS), Alejandro Cambiaso, president, and Amelia Reyes Mora, vice-president of the organization and president of AF Comunicación Estratégica, announced an investment of over 12 billion pesos in the medical tourism sector.

They stated that during the 6th International Congress on Health Tourism, a private investment breakfast will be held in conjunction with the financial sector. New ventures in this booming niche market will be presented, providing the country with thousands of jobs and innovative medical technologies and services.

Cambiaso said that the congress will be held on November 1 and 2 of this year at the JW Marriott Hotel in Santo Domingo and will feature multiple innovations and business opportunities, highlighting, above all, the talent of the Dominican medical class and its achievements, according to the program Esta Noche Mariasela.

Amelia Reyes Mora said the event will be a meeting point for multi-sector leaders. The country will be projected as a health and investment destination, promoting international accreditations and the projection of Dominican medicine.

It is noted that the DR is the leading destination for medical tourism in the Caribbean, number 2 in Latin America, and number 19 in the world, according to the Medical Tourism Index.

1 year 10 months ago

Health, tourism

Health Archives - Barbados Today

Region urged to prevent trans-border spread of infectious diseases

(CMC) – The Trinidad-based Caribbean Public Health Agency (CARPHA) says regional countries need to take adequate steps to prevent the trans-boundary spread of infectious diseases, describing it as a threat to regional and global health security.

CARPHA held a two-day conference in Trinidad and Tobago last week to discuss the devastating impact of the COVID-19 pandemic and other public health concerns, reiterating the necessity for regional and global health security to protect and improve health.

It said that Regional Health Security (RHS) encompasses the capacities required for the Caribbean to prepare for and respond to public health threats, risks, priority issues and concerns that transcend national boundaries and potentially impact on economic stability, trade, tourism, and access to goods and services in the region.

“RHS offers a coordinated approach which is especially crucial in the Caribbean as the region, like the Pacific and African small island developing states, is characterised by small, under-resourced populations and varying surveillance, laboratory and human resource capacities,” CARPHA said.

“It is also highly interconnected with porous borders, heavily reliant on tourism, and susceptible to climate change and disasters.”

The agency noted that this combination of factors significantly increases the region’s exposure and vulnerability to disease spread, enabling rapid spread of highly transmissible communicable diseases.

Furthermore, the tropical climate, and abundance of competent vectors make the region particularly vulnerable to vector-borne disease outbreaks.

“Consequently, regional health security and prevention, preparedness and response to public health emergencies need to be improved not only at the national levels, but at the regional level, as functional regional capacities are greater than the sum of the capacities of individual countries for improving RHS in the Caribbean,” CARPHA said.

“The major outcomes of this meeting include the detailing and prioritisation of member states’ current needs, increased awareness of CARPHA’s integrated surveillance and capacity building work and strengthening partnerships. These elements will assist in developing the sustainable RHS Pathway in short order.”

The post Region urged to prevent trans-border spread of infectious diseases appeared first on Barbados Today.

1 year 10 months ago

A Slider, Health, Regional

Jamaica Observer

When seconds count... count on CPR

Efficient
pre-hospital care plays a critical role in saving the lives of people experiencing medical emergencies.

Efficient
pre-hospital care plays a critical role in saving the lives of people experiencing medical emergencies.

In cardiac and respiratory emergencies, the focus is on performing early cardiopulmonary resuscitation (CPR), defibrillation, in field diagnostics (ECG telemetry), initiation of treatment (aspirin, nitrates) as per protocol, and rapid transport to hospitals with capabilities of treating with cardiac emergencies.

The above-mentioned are the ideal scenarios, but in resource-challenged environments such as ours, these ideals remain only aspirational.

The chain of survival is a conceptual framework in the Emergency Cardiac Care community that outlines a series of six vital steps that are necessary to maximise a person's chances of survival during cardiac arrest.

Let us assess the readiness of Jamaica to provide the chain of survival for victims of cardiac arrest.

Link 1. Activation of the emergency response

Early recognition and activation of the prehospital emergency response is the first link in the chain of survival. Currently there is limited public awareness about recognising cardiac arrest symptoms. As a result, delays in seeking medical help are very common, thus hampering the effectiveness of this link.

Link 2. High-quality CPR

The immediate initiation of bystander CPR is essential for the success of any emergency medical response for cardiac arrest. In Jamaica, bystander CPR rates are dismally low due to limited knowledge and training among the general population. Reluctance to perform CPR may also be influenced by cultural factors and the fear of doing harm.

Over the past two decades the Heart Foundation of Jamaica has been an advocate for layperson CPR training as well as providing training for both prehospital and in-hospital medical responders. However, greater efforts are required to educate citizens about performing CPR, and to dispel the fears of people who may be willing to learn.

Link 3. Early defibrillation

This link speaks to the early use of automated external defibrillators (AEDs) on patients who are in cardiac arrest. It is used to deliver a "shock' to the patient. This is the only treatment for patients who are in cardiac arrest due to the lethal cardiac rhythms of ventricular fibrillation or ventricular tachycardia.

The availability of AEDs in public spaces is very limited. This may be due to two factors — cost and absence of legislation. The need for public access defibrillation is a cornerstone of the thrust to strengthen the chain of survival.

Link 4. Early advanced care

Prehospital Emergency Medical Care in Jamaica currently has two operational systems. There is a formal Ministry of Health and Wellness (MOHW)/Ministry of Local Government and Community Development (MLG & CD) emergency medical service. This service is manned by emergency medical technicians (EMTs), from the fire brigade-trained to the basic EMT level. This emergency medical service (EMS) operates in the parishes of Westmoreland, St James, Trelawny, and St Catherine.

The other system is that of private EMS operators. These private services operate in all parishes and provide a greatly needed service, although, operationally, they are largely unregulated. Great strides have been made over the years in training emergency room staff in basic and advanced life support, but there are still resource issues in our emergency rooms, which mitigate against offering patients the full level of care that is routinely available in places with more resources.

Link 5. Integrated post-cardiac arrest care

All patients who have achieved return of spontaneous circulation (ROSC) require admission to an intensive care unit (ICU). This high level of care is required because the underlying cause of the cardiac arrest often still exists, and the patient is at great risk of going back into cardiac arrest. The Jamaican reality is that there are simply not enough ICU beds available for the population.

Link 6. Recovery

The sixth link is recovery. It focuses on the need for continued treatment and rehabilitation of cardiac arrest survivors. It also focuses on the families and caregivers of the survivors.

Critical concepts for recovery include:

• Comprehensive post-cardiac arrest discharge planning for survivors and their families and caregivers. This includes medical follow-up and rehabilitative treatment. Advice on return to activity and work and management of these expectations.

• Assessment and treatment of the cardiopulmonary, neurologic, and cognitive impairments that often affect cardiac arrest survivors.

• Assessment and treatment of the many psychiatric ailments which beset near-death experiences. These include anxiety, depression, post-traumatic stress, and chronic fatigue.

Unfortunately, there is little or no focus on this very important sixth link.

Recommendations

To enhance Jamaica's readiness in providing the chain of survival, the following strategies are suggested.

1. Initiate State-funded public education programmes about recognising the symptoms of cardiac arrest and the steps in performing CPR

2. Create cardiac-ready communities. This involves the establishment of communities that meet the criteria for having:

*Laypersons trained in CPR. Free CPR training to communities empowers the citizens to provide immediate help in emergencies.

*Public access to AEDs. Increasing the availability and deployment of AEDs in public spaces, workplaces, and transportation centres can decrease the time to defibrillation.

*Blood pressure, cholesterol, and diabetic screenings. Identifies groups at higher risk of cardiac arrest. Allows for intervention.

*A functional EMS. Ensures timely and effective prehospital care and transport.

*Investment in road infrastructure. Improving road networks and addressing traffic congestion can facilitate faster EMS response.

*A properly equipped and staffed emergency room in the local hospital.

While Jamaica has invested in its health-care professionals with an emphasis on training and the existence of public and private EMS, there are significant challenges that impede its readiness to provide all the links in the chain of survival. A chain is as strong as its weakest link; therefore, the thrust must be to strengthen all the links.

By addressing the recognised issues of public awareness, CPR training, AED availability, and resource allocation, Jamaica can strengthen its pre-hospital, in-hospital, and post-hospital care, and contribute to a more robust chain of survival.

CPR week is being observed in Jamaica from August 21-24.

Dr Hugh Wong DM (Emergency Medicine) is the director of emergency cardiac care at the Heart Foundation of Jamaica. He can be contacted at hmarkwong@gmail.com

1 year 10 months ago

Jamaica Observer

Foamy urine: What does it mean?

REGARDING bathroom habits, you likely don't pay much attention when everything goes smoothly. You might already be aware of some inconsequential changes, such as dark-yellow urine indicating dehydration, or the unpleasant odour that comes from consuming certain foods like asparagus. However, foamy urine might be a less familiar concept.

Foamy urine often suggests the presence of protein in the urine, which can be indicative of kidney issues. Your kidneys are responsible for filtering and retaining protein in your body, so if they're not functioning properly it can lead to protein leakage. Health conditions affecting the kidneys or other bodily systems like diabetes could also result in foamy urine.

Should your urine appear foamy consistently over several days and you experience additional symptoms like leg or eye swelling, consulting a doctor is advisable. Here are five potential reasons for foamy urine and corresponding actions to take if the issue occurs:

1. Urine stream: A certain degree of bubbles in urine is typical and can be influenced by the speed of urination and the distance the urine travels before reaching the toilet.

2. Dehydration: Urine contains water so inadequate fluid intake can lead to foamy urine. Greater dehydration leads to more concentrated urine, resulting in foaminess due to the higher concentration of substances in a smaller water volume. If you observe foamy urine, a useful initial step is to increase hydration. Consuming beverages with electrolytes can aid in hydration and maintaining salt levels, which often decrease when dehydrated. Severe dehydration can prompt muscle pain, dizziness, confusion, and breathing difficulties. Immediate medical attention is necessary if such symptoms occur.

3. Kidney disease: Normally the kidneys' filters prevent protein molecules from entering the urine. An increase in protein in urine typically signifies damaged filter functions. Foamy urine might be one sign of kidney damage, accompanied by symptoms like fluid retention-related swelling or weight gain. Consulting a doctor is recommended if these symptoms are present. A basic urine test by a primary care provider can reveal protein presence and quantity. Based on the results and medical history a nephrologist may be consulted for further blood tests to identify the cause and prescribe treatment.

4. Diabetes or hypertension: Once more, protein in urine plays a role. Both diabetes, (affecting insulin levels), and hypertension, (or high blood pressure), can impair kidney blood flow and function. Elevated pressure causes stress, leading to kidney damage and protein leakage, resulting in foaminess. Both conditions have other symptoms too — diabetes may cause increased urination and thirst while hypertension might manifest as chest pain or breathlessness. If these symptoms coincide with foamy urine, informing your doctor is advised. Management often involves oral medications and adopting a healthy lifestyle inclusive of exercise; a balanced diet low in sugar, calories, and salt; and moderate alcohol intake.

When to be concerned about foamy urine

If foamy urine occurs only once there's no immediate cause for concern. But if foamy urine becomes a regular occurrence or persists for days to a week, consulting a doctor is advisable. Pregnant individuals should be particularly cautious as protein in the urine could indicate pre-eclampsia — a serious condition. In such cases, promptly informing your doctor is essential.

Dr Jeremy Thomas is a consultant urologist. He works privately in Montego Bay, Savanna-la-Mar and Kingston, and publicly at Cornwall Regional Hospital. He may be contacted on Facebook and Instagram: @jthomasurology or by e-mail: jthomasurology@gmail.com

1 year 10 months ago

Jamaica Observer

The Americas seek to expand genomic surveillance for dengue, chikungunya, and other mosquito-borne viruses

PAHO, SANTO DOMINGO — Laboratory experts gathered recently in Santo Domingo, Dominican Republic, to discuss increasing the use of tools to detect and monitor mosquito-borne diseases in the Americas.

The meeting, led by the Pan American Health Organization (PAHO), comes as some countries in the region face large-scale outbreaks of dengue and intense circulation of chikungunya.

Members, which are made up of 35 national laboratories from across the region, technical advisors, and World Health Organisation (WHO) collaborating centres, will review ways to expand genomic and entomovirological surveillance to major arboviruses.

"At least nine arboviruses with public health impact — such as dengue, zika, chikungunya, and yellow fever — are circulating in Latin America and the Caribbean, so strengthening and expanding laboratory detection and surveillance capacities are key to ensuring a timely response to outbreaks and epidemics," Sylvain Aldighieri, deputy director of PAHO's Department of Health Emergencies, said.

Arboviruses are transmitted by the bite of arthropods (mosquitoes and ticks, among others). From the beginning of 2023 until the end of July, more than 3 million new dengue infections and more than 324,000 cases of chikungunya were reported in the Americas. With 27,000 cases across the region in the same period, Zika has a lower incidence rate, while sporadic cases of yellow fever represent a permanent risk of re-emergence of this potentially lethal disease.

"The epidemiological picture of arboviruses in the region is highly complex due to the epidemic potential of these diseases," José Luis San Martín, PAHO regional advisor on arboviral diseases, warned. "We must carry out an integrated prevention and control strategy that uses new innovations to closely monitor these viruses in laboratories," he added.

During the COVID-19 pandemic, genomic surveillance of SARS-CoV-2 proved key to understanding the virus, its variants, and advising public policy to prevent and control of the disease.

In the past years, investment and international cooperation have strengthened Arbovirus Diagnosis Laboratory Network of the Americas (RELDA) laboratories, and now at least eight countries in the region have introduced genomic sequencing within the framework of PAHO's Regional Strategy for Genomic Surveillance.

Many countries are taking advantage of these capacities and have started sequencing dengue, yellow fever, chikungunya, and other viruses, some for the first time. With RELDA's support, laboratories can expand this surveillance to find out the genomes of arboviruses circulating in their territory, their dispersion patterns, and analyse whether mutations are associated with greater transmissibility or severity.

For María Alejandra Morales, director of the PAHO/WHO Collaborating Centre on Viral Haemorrhagic Fevers and Arboviruses, National Institute of Human Viral Diseases (INEVH) in Argentina, "RELDA has a key role to play in the strengthening, growth, and continuous improvement of the laboratory component as part of an integrated management strategy for arboviruses."

Morales, who is currently the RELDA coordinator, also believes the expanded work of the laboratories with virological, serological, and molecular tests "will make it possible to generate timely and quality information for decision-making that can contribute to the prevention and control of arboviruses".

During the meeting, experts also discussed the status of entomovirological surveillance in the region, that is, the detection of viruses in mosquitoes before they reach humans. This type of surveillance, already conducted in some countries, can serve as an early warning system to anticipate arbovirus outbreaks or epidemics and allow for a more timely response.

PAHO began promoting entomovirological surveillance in 2017 and created the Entomo-Virological Laboratory Network (RELEVA), which currently includes laboratories in 14 countries. At the meeting, guidelines for this surveillance were presented and discussed. Laboratories in the network are also working on a plan for their implementation and plan to create a comprehensive arbovirus surveillance platform that includes mosquito surveillance data.

RELDA, which celebrates its 15th anniversary this year, is composed of 40 laboratories, technical advisors, and WHO collaborating centres, and is the operational arm of the laboratory component of PAHO's Integrated Management Strategy for Arboviral Disease Prevention and Control (known as IMS-arbovirus). Its main objective is to ensure efficient laboratory surveillance and a robust installed capacity to respond to arbovirus outbreaks and epidemics.

1 year 10 months ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

171 SR Post Vacancies: Apply Now At RML Hospital Delhi, View All Details Here

New Delhi: The Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital (ABVIMS and RML Hospital Delhi), has announced the vacancies for the post of Senior Resident (Non-Academic) on a regular basis in this medical institute.

Dr Ram Manohar Lohia Hospital, formerly known as Willingdon Hospital, was established by the British for their staff and had only 54 beds. After independence, its control was shifted to New Delhi Municipal Committee. In 1954, its control was again transferred to the Central Government of Independent India.

RML Hospital Vacancy Details:

Total no of vacancies: 171

The Vacancies are in the department of Biochemistry, Transfusion medicine(Blood Bank), Cardiac Anesthesia, ENT, Endocrinology, Forensic Medicine, Gastroenterology, Obstetrics & Gynaecology, Medicine, Microbiology, Neonatology, Ophthalmology, Orthopedics, Pediatrics, Pathology, Physical Medicine and Rehabilitation, Psychiatry, Radiology, Dermatology, Surgery, Anesthesia, Anatomy, Community Medicine, Respiratory Medicine, Physiology, and Pharmacology.

The last date and time of submission of the application is 25th August 2023 till 3:00 PM.

For more details about Qualifications, Age, Pay Allowance, and much more, click on the given link:

https://medicaljob.in/jobs.php?post_type=&job_tags=RML+Hospital&location=&job_sector=all

Eligible Candidates (How to Apply)?

1. The application should be submitted in the Central Diary & Dispatch Section, Near Gate No. 3, ABVIMS & Dr. Ram Manohar Lohia Hospitals New Delhi-110001, by 25.08.2023 till 03:00 PM.

2. The application should be accompanied by the latest passport-size photograph, copy of the fee receipt, and self-attested copes of all documents that should be delivered/received, either through Post or by Hand, in the name of the Director & Medical Superintendent.

3. The application sent by Post must be written prominently on the top of the envelope "Application for the Post of Senior Resident (Non-Academic) department. The Hospital will not be responsible for any Postal delay.

4. The candidates must submit a copy of the following documents (self-attested) along with the application form.

5. They should bring the original certificates at the time of the interview:

i. Certificate in support of age (10th class passing certificate).

ii. Mark Sheets of MBBS/BDS (All years).

iii. MBBS/BDS Attempt Certificate.

iv. Internship completion certificate.

v. MBBS/BDS Degree.

vi. PG Attempt Certificate.

vii. P.G. Degree/Diploma/Provisional Pass Certificate from University.

viii. DMC/DDC Registration certificate for PG/DNB/Diploma as prescribed in clause 2 a

ix. Caste/Community/Disability/EWS Certificate wherever applicable.

x. OBC Certificate only as per Annexure-II with required validity as mentioned at para 5 (b) above.

xi. NOC from present employer (if employed).

xii. Adhaar and PAN card.

xiii. Copy of fee receipt.

6. The candidates must submit the application in the prescribed form (Annexure I) and paste a recent passport-size photograph. All the documents must be self-attested including his/her photograph on the application form.

Also Read:Assistant Professor Post Vacancies At AIIMS Bhopal: View All Details Here

1 year 10 months ago

Jobs,State News,News,Health news,Delhi,Medical Jobs,Hospital & Diagnostics,Doctor News,Latest Health News,Recent Health News

Health | NOW Grenada

Minister actions on housing conditions in Mangrove, Carriacou

“The Minister, after assessing the housing conditions, said it’s unbelievable that citizens have been living in such conditions for years, with no proper help”

1 year 10 months ago

Carriacou & Petite Martinique, Community, Environment, Health, PRESS RELEASE, carriacou, Javan Williams, mangrove, ministry of carriacou and petite martinique affairs, tevin andrews

Health – Dominican Today

Director Moscoso Puello highlights the work of doctors on National Doctor’s Day

Santo Domingo.- On National Doctor’s Day, Maria Argentina Germán, the director of Hospital Doctor Francisco Moscoso Puello, extended her congratulations to doctors, particularly those within the center, for their dedicated work and commitment to ongoing training.

Santo Domingo.- On National Doctor’s Day, Maria Argentina Germán, the director of Hospital Doctor Francisco Moscoso Puello, extended her congratulations to doctors, particularly those within the center, for their dedicated work and commitment to ongoing training.

Representing the Moscoso Puello Hospital management alongside Deputy Director Dr. Ydalma Santos and Administrator Mr. Jesús Polanco, Dr. Germán encouraged doctors to continue delivering quality, compassionate, and empathetic care.

Geraldine Mir, in charge of the Internal Medicine service, highlighted this day as an occasion to recognize and honor the efforts of healthcare professionals who approach each day with determination, optimism, responsibility, and dedication to providing health to those in need.

Dr. Mir emphasized that doctors should maintain emotional stability and consistent health. She advised aspiring medical students to forge strong patient relationships and emphasized that while medicine requires sacrifices, pursuing the field with passion, humility, and simplicity can lead to success.

This commemoration serves as a fitting tribute to doctors, who dedicate themselves to ensuring citizens’ health and well-being.

The call is for doctors to uphold the ethical principles of medicine, focusing on humanized care to secure citizens’ right to health.

Dominican Doctor’s Day, celebrated every August 18, marks the founding of the Dominican Medical Association, later known as the Dominican Medical College (CMD).

The hospital’s doctors cover various departments, including allergology, pathology, anesthesiology, comprehensive care, cardiology, general surgery, cancer surgery, reconstructive surgery, thoracic surgery, vascular surgery, coloproctology, dermatology, diabetology, emergency, and endocrinology. The list extends to epidemiology, gastroenterology, geriatrics, gynecology, hematology, imaging, infectious diseases, internal medicine, nephrology, pulmonology, neurosurgery, neurology, clinical nutrition, dentistry, ophthalmology, clinical oncology, orthopedics, otorhinolaryngology, pediatrics, psychology, psychiatry, rheumatology, urology, and various specialized units.

1 year 10 months ago

Health

Health – Dominican Today

Executive director of the National Health Insurance says the Dominican Republic has the best health system in Latin America

Santo Domingo.- Santiago Hazim, the Executive Director of the National Health Insurance (Senasa), has confidently declared that the Dominican Republic boasts the most outstanding healthcare system across Latin America and even extends its influence into parts of North America.

Santo Domingo.- Santiago Hazim, the Executive Director of the National Health Insurance (Senasa), has confidently declared that the Dominican Republic boasts the most outstanding healthcare system across Latin America and even extends its influence into parts of North America.

This assertion is firmly grounded in the nation’s achievement of universalizing its healthcare system. Notably, the country’s coverage encompasses expenses up to two million pesos for an array of ailments, treatments, and essential medical procedures.

In a recent interview on the Despierta program with CDN, Hazim bolstered his claim by highlighting the extraordinary scope provided by the Dominican health system. He emphasized that this coverage extends to high-cost illnesses like cancer, organ transplants, chemotherapy, intricate surgeries, and neurosurgery.

Furthermore, this comprehensive coverage has yielded tranquility for patients, assuring them protection against various medical conditions, encompassing dialysis and other pathologies. This level of security, Hazim emphasized, is even absent in the United States.

Hazim contrasted the Dominican and American healthcare systems, revealing that in the United States, patients often grapple with substantial hurdles involving costs and prolonged waiting periods for medical care. Conversely, the Dominican health system ensures prompt and accessible care.

Dr. Hazim acknowledged that despite these commendable strides, the Dominican healthcare system still contends with deficiencies. Specifically, he mentioned the need to enhance imaging capabilities, such as X-ray equipment, 3D CT scans, and MRIs. He attributed these shortcomings to a cultural inclination and proximity to the United States, which fosters familiarity with cutting-edge medical technologies and advancements.

He further illustrated the situation, stating that the capacity for expanded coverage requires deliberation. Senasa, for instance, cannot unilaterally decide to cover laparoscopic surgery; an actuarial study by Sisalril (Superintendence of Health and Occupational Risks) is imperative to ascertain the frequency of such surgeries in the country, their costs at different facilities, and subsequently determine an average allocation for each ARS.

In closing, Hazim underlined the paramount importance of upholding the stability of social security and the healthcare system within the nation.

1 year 10 months ago

Health

Healio News

Patients with undiagnosed psoriatic arthritis, axial SpA often ‘bounced’ around providers

Patients with axial spondyloarthritis and psoriatic arthritis routinely “bounce” from one provider to the next for years before finally receiving the correct diagnosis in a rheumatology clinic, according to experts.Diagnostic delay is the obvious consequence. Patients may live with the condition for months or years before being treated and managed appropriately.

Downstream consequences — including more severe disease, increased therapeutic challenges and reduced quality of life, among others — usually ensue.For patients with axial SpA, part of the issue is that low

1 year 10 months ago

KFF Health News

A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their Drugs

America’s pharmaceutical giants are suing this summer to block the federal government’s first effort at drug price regulation.

America’s pharmaceutical giants are suing this summer to block the federal government’s first effort at drug price regulation.

Last year’s Inflation Reduction Act included what on its face seems a modest proposal: The federal government would for the first time be empowered to negotiate prices Medicare pays for drugs — but only for 10 very expensive medicines beginning in 2026 (an additional 15 in 2027 and 2028, with more added in later years). Another provision would require manufacturers to pay rebates to Medicare for drug prices that increased faster than inflation.

Those provisions alone could reduce the federal deficit by $237 billion over 10 years, the Congressional Budget Office has calculated. That enormous savings would come from tamping down drug prices, which are costing an average of 3.44 times — sometimes 10 times — what the same brand-name drugs cost in other developed countries, where governments already negotiate prices.

These small steps were an attempt to rein in the only significant type of Medicare health spending — the cost of prescription drugs — that has not been controlled or limited by the government. But they were a call to arms for the pharmaceutical industry in a battle it assumed it had won: When Congress passed the Medicare prescription drug coverage benefit (Part D) in 2003, intense industry lobbying resulted in a last-minute insertion prohibiting Medicare from negotiating those prices.

Without any guardrails, prices for some existing drugs have soared, even as they have fallen sharply in other countries. New drugs — some with minimal benefit — have enormous price tags, buttressed by lobbying and marketing.

AZT, the first drug to successfully treat HIV/AIDS, was labeled “the most expensive drug in history” in the late 1980s. Its $8,000-a-year cost was derided as “inhuman” in a New York Times op-ed. Now, scores of drugs, many with much less benefit, cost more than $50,000 a year. Ten drugs, mostly used to treat rare diseases, cost over $700,000 annually.

Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it to market nor its therapeutic value.

And selling drugs first in the U.S. is a good business strategy. By introducing a drug in a developed country with limited scrutiny on price, manufacturers can set the bar high for negotiating with other nations.

Here are just a few of the many examples of drug pricing practices that have driven consumers to demand change.

Exhibit A is Humira, the best-selling drug in history, earning AbbVie $200 billion over two decades. Effective in the treatment of various autoimmune diseases, its core patent — the one on the biologic itself — expired in 2016. But for business purposes, the “controlling patent,” the last to expire, is far more important since it allows an ongoing monopoly.

AbbVie blanketed Humira with 165 peripheral patents, covering things like a manufacturing step or slightly new formulation, creating a so-called patent thicket, making it challenging for generics makers to make lower-cost copycats. (When they threatened to do so, AbbVie often offered them valuable deals not to enter the market.) Meanwhile, it continued to raise the price of the drug, most recently to $88,000 a year. This year, Humira-like generics (called biosimilars for its type of molecule) are entering the U.S. market; they have been available for a fraction of the price in Europe for five years.

Or take Revlimid, a drug by Celgene (now part of Bristol Myers Squibb), which treats multiple myeloma. It won FDA approval to treat that previously deadly disease in 2006 at about $4,500 a month; today it retails at triple that. Why? The company’s CEO explained price hikes were simply a “legitimate opportunity” to improve financial “performance.”

Since it must be taken for life to keep that cancer in check, patients who want to live (or their insurers) have had no choice but to pay. Though Revlimid’s patent protection ran out in 2022, Celgene avoided meaningful price-cutting competition by offering generic competitors “volume-limited licenses” to its patents so long as they agreed to initially produce a small share of the drug’s $12 billion monopoly market.

Par Pharmaceutical, another drugmaker, maneuvered to create a blockbuster market out of a centuries-old drug, isoproterenol, through a well-meaning FDA program that gave companies a three-year monopoly in exchange for performing formal testing on drugs in use before the agency was formed.

During those three years, Par wrapped its branded product, Vasostrict, used to maintain blood pressure in critically ill patients, with patents — including one on the compound’s pH level — extending its monopoly eight additional years. Par raised the price by 5,400% between 2010 and 2020. When the covid-19 pandemic filled intensive care units with severely ill patients, that hike cost Americans $600 million to $900 million in the first year.

And then there is AZT and its successors, which offer a full life to HIV-positive people. Pills today contain a combination of two or three medicines, the vast majority including one similar to AZT, tenofovir, made by Gilead Sciences. The individual medicines are old, off-patent. Why then do these combination pills, taken for life, sometimes cost $4,000 monthly?

It’s partly because many manufacturers of the combination pills have agreements with Gilead that they will use its expensive branded version of tenofovir in exchange for various business favors. Peter Staley, an activist with HIV, has been spearheading a class-action suit against Gilead, alleging “collusion.” The negotiated price for these pills is hundreds of dollars a month in the United Kingdom, not the thousands charged in the U.S.

Faced with such tactics, 8 in 10 Americans now support drug price negotiation, giving Congress and the Biden administration the impetus to act and to resist Big Pharma’s legal challenges, which many legal experts view as a desperate attempt to stave off the inevitable.

“I don’t think they have a good legal case,” said Aaron Kesselheim, who studies drug pricing at Harvard Medical School. “But it can delay things if they can find a judge to issue an injunction.” And even a year’s delay could translate into big money.

Yes, American patients are lucky to have first access to innovative drugs. And, sadly, patients in countries that refuse to pay up once in a while go without the latest treatment. But more sadly, polling shows, large numbers of Americans are forgoing prescribed medicines because they can’t afford them.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 10 months ago

Health Care Costs, Health Care Reform, Health Industry, Pharmaceuticals, Drug Costs, Legislation, Prescription Drugs

Pages